Ligand Pharmaceuticals Q1 Adjusted Earnings Beat
May 04, 2016 at 07:16 AM EDT
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) reported net income attributable to its shareholders of $6.61 million or $0.30 a share, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.